Zions Bancorporation, National Association’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.4M Buy
41,284
+6,285
+18% +$1.35M 0.62% 17
2026
Q1
$7.61M Sell
34,999
-9,204
-21% -$2.04M 0.49% 33
2025
Q4
$10.1M Sell
44,203
-12,395
-22% -$2.82M 0.47% 26
2025
Q3
$13.1M Sell
56,598
-9,468
-14% -$1.93M 0.65% 22
2025
Q2
$12.3M Buy
66,066
+4,730
+8% +$879K 0.66% 19
2025
Q1
$12.9M Buy
+61,336
New +$11.9M 0.81% 15

Other funds holding ABBV

Zions Bancorporation, National Association's ABBV Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its AbbVie (ABBV) stake by 18% in Q2 2026, buying an estimated $1.35M and bringing the position to 41,284 shares worth $10.4M. The position accounts for 0.62% of the portfolio, ranked #17.

Zions Bancorporation, National Association first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. The position peaked at $13.1M in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Zions Bancorporation, National Association held 41,284 shares of AbbVie worth $10.4M as of Q2 2026.
  • Zions Bancorporation, National Association bought 6,285 AbbVie shares in Q2 2026, an estimated $1.35M.
  • AbbVie made up 0.62% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #17 holding.
  • Zions Bancorporation, National Association first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • Zions Bancorporation, National Association's AbbVie position peaked at $13.1M in Q3 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.